keyword
MENU ▼
Read by QxMD icon Read
search

Hiv incidence assay

keyword
https://www.readbyqxmd.com/read/28592547/performance-of-the-abbott-realtime-mtb-and-mtb-rif-inh-assays-in-a-high-tb-and-hiv-coinfection-setting-in-south-africa
#1
Lesley Scott, Anura David, Lara Noble, Matilda Nduna, Pedro Da Silva, Andrew Black, Francois Venter, Wendy Stevens
Background: South Africa is a country with a high incidence of tuberculosis (TB), complicated by coinfection with HIV. The Xpert MTB/RIF (Cepheid, Sunnyvale, CA, USA) is used in South Africa as the test for initial diagnosis of TB, and other molecular platforms such as the m2000 (Abbott Molecular, Des Plaines, IL, USA) are widely used for molecular monitoring of HIV viral load. This latter platform is now also equipped with the RealTime MTB and RealTime MTB RIF/INH assays for TB and first line drug resistance screening, but has not been evaluated in settings of HIV and TB coinfection...
June 7, 2017: Journal of Clinical Microbiology
https://www.readbyqxmd.com/read/28584337/-hbv-hcv-and-hiv-infection-prevalence-among-prison-staff-in-the-light-of-occupational-risk-factors
#2
Maria Gańczak, Zbigniew Szych
BACKGROUND: Objectives of the study: to assess the occupational risk for blood-borne infections (BBIs) among prison staff (number/ circumstances of blood exposures and preventive methods used), and to estimate the prevalence of hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV). MATERIAL AND METHODS: The survey, which included serological testing with the use of 3-generation enzyme-linked immunosorbent assays (ELISA) was completed on active staff at a correctional facility in Goleniów, Poland, between June-July 2015...
May 15, 2017: Medycyna Pracy
https://www.readbyqxmd.com/read/28493891/antibody-to-hsv-gd-peptide-induced-by-vaccination-does-not-protect-against-hsv-2-infection-in-hsv-2-seronegative-women
#3
Peter B Gilbert, Jean-Louis Excler, Georgia D Tomaras, Lindsay N Carpp, Barton F Haynes, Hua-Xin Liao, David C Montefiori, Supachai Rerks-Ngarm, Punnee Pitisuttithum, Sorachai Nitayaphan, Jaranit Kaewkungwal, Gustavo H Kijak, Sodsai Tovanabutra, Donald P Francis, Carter Lee, Faruk Sinangil, Phillip W Berman, Nakorn Premsri, Prayura Kunasol, Robert J O'Connell, Nelson L Michael, Merlin L Robb, Rhoda Morrow, Lawrence Corey, Jerome H Kim
BACKGROUND: In the HIV-1 vaccine trial RV144, ALVAC-HIV prime with an AIDSVAX® B/E boost reduced HIV-1 acquisition by 31% at 42 months post first vaccination. The bivalent AIDSVAX® B/E vaccine contains two gp120 envelope glycoproteins, one from the subtype B HIV-1 MN isolate and one from the subtype CRF01_AE A244 isolate. Each envelope glycoprotein harbors a highly conserved 27-amino acid HSV-1 glycoprotein D (gD) tag sequence that shares 93% sequence identity with the HSV-2 gD sequence...
2017: PloS One
https://www.readbyqxmd.com/read/28472089/performance-characteristics-of-an-antibody-based-multiplex-kit-for-determining-recent-hiv-1-infection
#4
Kelly A Curtis, Debra L Hanson, Krystin Ambrose Price, S Michele Owen
The availability of reliable laboratory methods for determining recent HIV infection is vital for accurate estimation of population-based incidence. The mean duration of recent infection (MDRI) and false recent rate (FRR) are critical parameters for HIV incidence assays, as they impact HIV incidence estimates and provide a measure of assay performance. The HIV-1 Multiplex assay is an in-house developed, magnetic bead-based assay that measures virus-specific antibody levels and avidity to multiple analytes. To ensure quality control and to facilitate transfer of the assay to external laboratories or testing facilities, the in-house assay has been adapted and produced in kit form...
2017: PloS One
https://www.readbyqxmd.com/read/28471839/impact-of-early-antiretroviral-therapy-on-the-performance-of-hiv-rapid-tests-and-hiv-incidence-assays
#5
Jessica M Fogel, Estelle Piwowar-Manning, Barbara Debevec, Tamara Walsky, Katherine Schlusser, Oliver Laeyendecker, Ethan A Wilson, Marybeth McCauley, Theresa Gamble, Gerald Tegha, MTech Biomed, Dean Soko, Johnstone Kumwenda, Mina C Hosseinipour, Ying Q Chen, Myron S Cohen, Susan H Eshleman
BACKGROUND: Antiretroviral therapy (ART) can down-regulate antibody responses to HIV infection. We evaluated the impact of early vs. delayed ART on the performance of HIV diagnostic and incidence assays. METHODS: Samples were obtained from 207 participants in the HPTN 052 trial who were stably suppressed on ART for ≥4 years (Malawi sites; pre-ART CD4 cell count 350-550 cells/mm [early ART arm, N=180] or <250 cells/mm or an AIDS-defining illness [delayed ART arm, N=27])...
April 26, 2017: Journal of Acquired Immune Deficiency Syndromes: JAIDS
https://www.readbyqxmd.com/read/28443672/heightened-hiv-antibody-responses-in-postpartum-women-as-exemplified-by-recent-infection-assays-implications-for-incidence-estimates
#6
John Hargrove, Cari van Schalkwyk, Jean Humphrey, Kuda Mutasa, Robert Ntozini, Michele Owen, Silvina Masciotra, Bharat Parekh, Yen T Duong, Trudy Dobbs, Peter Kilmarx, Elizabeth Gonese
BACKGROUND: Laboratory assays that identify recent HIV infections are important for assessing impacts of interventions aimed at reducing HIV incidence. Kinetics of HIV humoral responses can vary with inherent assay properties, and between HIV subtypes, populations and physiological states. They are important in determining mean duration of recent infection (MDRI) for antibody-based assays for detecting recent HIV infections. METHODS: We determined MDRIs for BED-CEIA, LAg and BRAI assays for 101 seroconverting postpartum women, recruited in Harare in 1997- 2000 during the Zimbabwe Vitamin A for Mothers and Babies (ZVITAMBO) Trial, comparing them against published MDRIs estimated from seroconverting cases in the general population...
April 26, 2017: AIDS Research and Human Retroviruses
https://www.readbyqxmd.com/read/28408224/one-drug-for-two-targets-biological-evaluation-of-antiretroviral-agents-endowed-with-antiproliferative-activity
#7
Lorenzo Botta, Giorgio Maccari, Pierpaolo Calandro, Marika Tiberi, Annalaura Brai, Claudio Zamperini, Filippo Canducci, Mario Chiariello, Rosa Martí-Centelles, Eva Falomir, Miguel Carda
AIDS-related cancer diseases are malignancies with low incidence on healthy people that affect mostly subjects already immunocompromised. The connection between HIV/AIDS and these cancers has not been established yet, but a weakened immune system is certainly the main cause. We envisaged the possibility to screen a small library of compounds synthesized in our laboratory against opportunistic tumors mainly due to HIV infection like Burkitt's Lymphoma. From cellular assays and gene expression analysis we identified two promising compounds...
April 1, 2017: Bioorganic & Medicinal Chemistry Letters
https://www.readbyqxmd.com/read/28400821/the-great-impostor-transaminitis-masking-the-coinfection-of-syphilis-and-human-immunodeficiency-virus
#8
Sunit Tolia, Hassan Kassem, Ana Capatina-Rata
Introduction. The incidence of syphilis continues to rise in the United States over the past 15 years. This disease process is classified into stages and may present with a coinfection of Human Immunodeficiency Virus (HIV). Case Report. We present a case of a 32-year-old African American male who presented with cutaneous manifestations of secondary syphilis and transaminitis. A workup revealed that the transaminitis was secondary to underlying syphilitic hepatitis in the presence of HIV coinfection. The patient had a reactive rapid plasma reagin (RPR) of 1 : 64 TU and reactive Treponema pallidum particle agglutination assay (TPPA)...
2017: Case Reports in Medicine
https://www.readbyqxmd.com/read/28389206/residual-risk-of-hiv-hcv-and-hbv-in-canada
#9
Sheila F O'Brien, Qi-Long Yi, Wenli Fan, Vito Scalia, Mindy Goldman, Margaret A Fearon
BACKGROUND: Residual risk is estimated as the product of the incidence and the infectious window period, the time during which a blood donation could be infectious but the assay may not detect it. In 2011 nucleic acid multiplex testing (MPX) was implemented in 6 unit minipools (previously 24 unit minipools). MPX also included hepatitis B (HBV) NAT for the first time (complementing HBsAg screening) in addition to HIV-1 and hepatitis C (HCV) as before. We aimed to estimate window period risk-day equivalents for MPX, and the residual risk of viral infections in blood donations updated to reflect current incidence and testing...
March 18, 2017: Transfusion and Apheresis Science
https://www.readbyqxmd.com/read/28369198/contribution-of-serologic-assays-in-the-evaluation-of-influenza-virus-infection-rates-and-vaccine-efficacy-in-pregnant-women-report-from-randomized-controlled-trials
#10
Shabir A Madhi, Marta C Nunes, Adriana Weinberg, Locadiah Kuwanda, Andrea Hugo, Stephanie Jones, Nadia van Niekerk, Justin R Ortiz, Kathleen M Neuzil, Keith P Klugman, Eric A F Simões, Clare L Cutland
Background.: The utility of serologic testing to evaluate vaccine efficacy of seasonal inactivated influenza vaccine (IIV) is controversial. We aimed to evaluate the efficacy of IIV against serologically diagnosed influenza infection (SDI) and reverse-transcription polymerase chain reaction-confirmed influenza illness (PCR-CI) in women vaccinated during pregnancy. Methods.: We undertook a post hoc analysis of 2 randomized clinical trials evaluating IIV efficacy among human immunodeficiency virus (HIV)-uninfected and HIV-infected pregnant women...
June 15, 2017: Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
https://www.readbyqxmd.com/read/28364412/the-validation-and-evaluation-of-anti-hiv-testing-algorithm-used-in-mobile-clinic-setting-for-men-who-have-sex-with-men-in-metropolitan-bangkok-thailand
#11
Tippawan Pankam, Sarun Saensiriphan, Suphackok Areeyolwattana, Napapat Barisri, Supabhorn Pengnonyang, Sunee Sirivichayakul, Nittaya Phanuphak, Praphan Phanuphak
BACKGROUND: Same-day anti-HIV testing algorithm is recommended by Thai National Guidelines. We compared performance characteristics of algorithms used in a mobile clinic and a facility-based clinic for men who have sex with men (MSM) in Bangkok. METHODS: Mobile clinic samples collected from 4 saunas and 2 spa venues were tested by Alere DetermineTM HIV 1/2, followed by DoubleCheck GoldTM Ultra HIV 1/2 and SD Bioline HIV 1/2 3.0. All samples were re-tested at the Thai Red Cross Anonymous Clinic (TRCAC) by Architect HIV Ag/Ab or Elecsys HIV combi PT, followed by Alere DetermineTM HIV 1/2 and Serodia HIV 1/2...
April 1, 2017: Asian Pacific Journal of Allergy and Immunology
https://www.readbyqxmd.com/read/28318310/short-communication-comparison-of-maxim-and-sedia-limiting-antigen-assay-performance-for-measuring-hiv-incidence
#12
Katherine E Schlusser, Jacob Konikoff, Allison R Kirkpatrick, Charles Morrison, Tsungai Chipato, Pai-Lien Chen, Marshall Munjoma, Susan H Eshleman, Oliver Laeyendecker
Accurate methods for cross-sectional incidence estimation are needed for HIV prevention research. The Limiting Antigen Avidity (LAg-Avidity) assay has been marketed by two vendors, Maxim Biomedical and Sedia BioSciences Corporation. Performance differences between the two versions of the assay are unknown. We tested a total 1,410 treatment-naive samples with both versions of the assay. The samples came from 176 seroconverters from the Zimbabwe Hormonal Contraception and HIV Study. The correlation between the two versions of the assay was 0...
June 2017: AIDS Research and Human Retroviruses
https://www.readbyqxmd.com/read/28231277/comparison-of-cross-sectional-hiv-incidence-assay-results-from-dried-blood-spots-and-plasma
#13
Katherine E Schlusser, Christopher Pilcher, Esper G Kallas, Breno R Santos, Steven G Deeks, Shelley Facente, Sheila M Keating, Michael P Busch, Gary Murphy, Alex Welte, Thomas Quinn, Susan H Eshleman, Oliver Laeyendecker
BACKGROUND: Assays have been developed for cross-sectional HIV incidence estimation using plasma samples. Large scale surveillance programs are planned using dried blood spot (DBS) specimens for incidence assessment. However, limited information exists on the performance of HIV cross-sectional incidence assays using DBS. METHODS: The assays evaluated were: Maxim HIV-1 Limiting Antigen Avidity EIA (LAg-Avidity), Sedia HIV-1 BED-Capture EIA (BED-CEIA), and CDC modified BioRad HIV-1/2 Plus O Avidity-based Assay (CDC-BioRad Avidity) using pre-determined cutoff values...
2017: PloS One
https://www.readbyqxmd.com/read/28222702/the-virological-durability-of-first-line-art-among-hiv-positive-adult-patients-in-resource-limited-settings-without-virological-monitoring-a-retrospective-analysis-of-dart-trial-data
#14
David I Dolling, Ruth L Goodall, Michael Chirara, James Hakim, Peter Nkurunziza, Paula Munderi, David Eram, Dinah Tumukunde, Moira J Spyer, Charles F Gilks, Pontiano Kaleebu, David T Dunn, Deenan Pillay
BACKGROUND: Few low-income countries have virological monitoring widely available. We estimated the virological durability of first-line antiretroviral therapy (ART) after five years of follow-up among adult Ugandan and Zimbabwean patients in the DART study, in which virological assays were conducted retrospectively. METHODS: DART compared clinically driven monitoring with/without routine CD4 measurement. Annual plasma viral load was measured on 1,762 patients. Analytical weights were calculated based on the inverse probability of sampling...
February 21, 2017: BMC Infectious Diseases
https://www.readbyqxmd.com/read/28215501/serial-quantiferon-testing-and-tuberculosis-disease-risk-among-young-children-an-observational-cohort-study
#15
Jason R Andrews, Elisa Nemes, Michele Tameris, Bernard S Landry, Hassan Mahomed, J Bruce McClain, Helen A Fletcher, Willem A Hanekom, Robin Wood, Helen McShane, Thomas J Scriba, Mark Hatherill
BACKGROUND: The value of quantitative interferon-γ release assay results for predicting progression from Mycobacterium tuberculosis infection to active disease is unknown. We aimed to investigate the relation between QuantiFERON-TB Gold In-Tube (QFT) conversion interferon-γ values and risk of subsequent active tuberculosis disease and of QFT reversion. METHODS: We analysed data from a reported vaccine efficacy trial of the tuberculosis vaccine MVA85A in South Africa...
April 2017: Lancet Respiratory Medicine
https://www.readbyqxmd.com/read/28193090/estimating-false-recent-classification-for-the-limiting-antigen-avidity-eia-and-bed-capture-enzyme-immunoassay-in-vietnam-implications-for-hiv-1-incidence-estimates
#16
Neha S Shah, Yen T Duong, Linh-Vi Le, Nguyen Anh Tuan, Bharat S Parekh, Hoang Thi Thanh Ha, Quang Duy Pham, Cao Thi Thu Cuc, Trudy Dobbs, Tran Hong Tram, Truong Thi Xuan Lien, Nick Wagar, Chunfu Yang, Amy Martin, Mitchell Wolfe, Nguyen Tran Hien, Andrea A Kim
Laboratory tests that can distinguish recent from long-term HIV infection are used to estimate HIV incidence in a population, but can potentially misclassify a proportion of long-term HIV infections as recent. Correct application of an assay requires determination of the proportion false recents (PFRs) as part of the assay characterization and for calculating HIV incidence in a local population using a HIV incidence assay. From April 2009 to December 2010, blood specimens were collected from HIV-infected individuals attending nine outpatient clinics (OPCs) in Vietnam (four from northern and five from southern Vietnam)...
June 2017: AIDS Research and Human Retroviruses
https://www.readbyqxmd.com/read/28185617/mycobacterium-kansasii
#17
James C Johnston, Leslie Chiang, Kevin Elwood
The incidence of Mycobacterium kansasii varies widely over time and by region, but this organism remains one of the most clinically relevant isolated species of nontuberculous mycobacteria. In contrast to other common nontuberculous mycobacteria, M. kansasii is infrequently isolated from natural water sources or soil. The major reservoir appears to be tap water. Infection is likely acquired through the aerosol route, with low infectivity in regions of endemicity. Human-to-human transmission is thought not to occur...
January 2017: Microbiology Spectrum
https://www.readbyqxmd.com/read/28159730/hiv-trends-in-the-united-states-diagnoses-and-estimated-incidence
#18
H Irene Hall, Ruiguang Song, Tian Tang, Qian An, Joseph Prejean, Patricia Dietz, Angela L Hernandez, Timothy Green, Norma Harris, Eugene McCray, Jonathan Mermin
BACKGROUND: The best indicator of the impact of human immunodeficiency virus (HIV) prevention programs is the incidence of infection; however, HIV is a chronic infection and HIV diagnoses may include infections that occurred years before diagnosis. Alternative methods to estimate incidence use diagnoses, stage of disease, and laboratory assays of infection recency. Using a consistent, accurate method would allow for timely interpretation of HIV trends. OBJECTIVE: The objective of our study was to assess the recent progress toward reducing HIV infections in the United States overall and among selected population segments with available incidence estimation methods...
February 3, 2017: JMIR Public Health and Surveillance
https://www.readbyqxmd.com/read/28152432/rates-and-determinants-of-incidence-and-clearance-of-cervical-hpv-genotypes-among-hiv-seropositive-women-in-pune-india
#19
Arati Mane, Vikrant V Sahasrabuddhe, Amit Nirmalkar, Arun R Risbud, Seema Sahay, Ramesh A Bhosale, Sten H Vermund, Sanjay M Mehendale
BACKGROUND: Several studies in recent years have documented the genotype-specific prevalence of HPV infection and wide diversity and multiplicity of HPV genotypes among HIV-seropositive women. Yet, information on changes in HPV genotype-specific incidence and clearance rates over time, and their correlation with clinical or immunologic factors among HIV-seropositive women is scarce. OBJECTIVES: We conducted a prospective study to investigate the incidence and clearance rates of cervical HPV genotypes among HIV-seropositive women in India and expand the evidence base in this area of research...
March 2017: Journal of Clinical Virology: the Official Publication of the Pan American Society for Clinical Virology
https://www.readbyqxmd.com/read/28141782/effect-of-pregnancy-on-interferon-gamma-release-assay-and-tuberculin-skin-test-detection-of-latent-tb-infection-among-hiv-infected-women-in-a-high-burden-setting
#20
COMPARATIVE STUDY
Sylvia M LaCourse, Lisa M Cranmer, Daniel Matemo, John Kinuthia, Barbra A Richardson, David J Horne, Grace John-Stewart
BACKGROUND: Peripartum immunologic changes may affect latent tuberculosis infection (LTBI) diagnostic performance among HIV-infected women. METHODS: HIV-infected women were serially tested with tuberculin skin test (TST) and interferon gamma release assay [QuantiFERON TB Gold In-tube (QFT)] in pregnancy and 6 weeks postpartum in Kenya. Prevalence, sensitivity and agreement, and correlates of QFT/TST positivity were assessed. Quantitative QFT mitogen and Mycobacterium tuberculosis antigen (Mtb-Ag) responses were compared by peripartum stage...
May 1, 2017: Journal of Acquired Immune Deficiency Syndromes: JAIDS
keyword
keyword
39529
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"